Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
REGN Coverage
Event
Regeneron Pharmaceuticals Inc (REGN) Q1 2026 Earnings Announcement
Mar 25, 2026
Event
Regeneron Pharmaceuticals Inc (REGN) Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
Mar 24, 2026
Event
Regeneron Pharmaceuticals Inc (REGN) Q1 2025 Earnings Call
Mar 18, 2026
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript
Feb 2, 2026
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%
May 4, 2023
Press Release
Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%
Feb 3, 2023